Regulation / Healthcare Regulation
Companies operating in the life sciences sector, whether established global corporations or early-stage startups, face a highly regulated environment and complex legal challenges. Failure to properly implement regulatory requirements may delay market entry, increase costs, reduce return on investment, expose companies to legal risks, and even affect patient safety and public health.
Our firm provides comprehensive legal services to Israeli companies and international corporations operating in Israel across the pharmaceutical, biotechnology, medical device, diagnostics, research and development, and imaging sectors. The regulatory landscape in this field is complex and constantly evolving, affecting companies at every stage, from development through marketing and distribution.
Our legal counsel covers all relevant regulatory matters, including intellectual property protection and strategy, privacy and data protection, cross-border transfer of know-how, and consumer protection laws. We also assist companies in adapting to regulatory changes, implementing new requirements, and representing them before the relevant authorities when necessary.
In addition, our firm povides ongoing legal support to life sciences companies on matters relating to product development, registration and licensing, grant applications, distribution, and commercialization.
Adv. Efrat Cohen, a senior partner in the department, has extensive experience representing local and international pharmaceutical companies, medical device companies, and medical institutions in complex regulatory proceedings before government ministries, Knesset committees, and regulatory authorities. Her expertise includes licensing, budgeting, price regulation, registration of medical products, the drafting of regulations and legislation, and the negotiation of contracts and commercial arrangements.
Insights & News - Regulation / Healthcare Regulation:
Drug Registration Reform in Israel: Processes Are Being Streamlined and Time Frames Shortened to Increase Supply and Lower Prices
Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog
Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million
Regulation / Healthcare Regulation
Companies operating in the life sciences sector, whether established global corporations or early-stage startups, face a highly regulated environment and complex legal challenges. Failure to properly implement regulatory requirements may delay market entry, increase costs, reduce return on investment, expose companies to legal risks, and even affect patient safety and public health.
Our firm provides comprehensive legal services to Israeli companies and international corporations operating in Israel across the pharmaceutical, biotechnology, medical device, diagnostics, research and development, and imaging sectors. The regulatory landscape in this field is complex and constantly evolving, affecting companies at every stage, from development through marketing and distribution.
Our legal counsel covers all relevant regulatory matters, including intellectual property protection and strategy, privacy and data protection, cross-border transfer of know-how, and consumer protection laws. We also assist companies in adapting to regulatory changes, implementing new requirements, and representing them before the relevant authorities when necessary.
In addition, our firm povides ongoing legal support to life sciences companies on matters relating to product development, registration and licensing, grant applications, distribution, and commercialization.
Adv. Efrat Cohen, a senior partner in the department, has extensive experience representing local and international pharmaceutical companies, medical device companies, and medical institutions in complex regulatory proceedings before government ministries, Knesset committees, and regulatory authorities. Her expertise includes licensing, budgeting, price regulation, registration of medical products, the drafting of regulations and legislation, and the negotiation of contracts and commercial arrangements.